{"id":"W4200118952","doi":"10.3390/curroncol28060426","title":"Durable Response to Brentuximab Vedotin Plus Cyclophosphamide, Doxorubicin, and Prednisone (BV-CHP) in a Patient with CD30-Positive PTCL Arising as a Post-Transplant Lymphoproliferative Disorder (PTLD)","year":2021,"lang":"en","type":"article","venue":"Current Oncology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Brentuximab vedotin; Medicine; CD30; Internal medicine; Cyclophosphamide; Oncology; Lymphoproliferative disorders; Prednisone; Chemotherapy; Lymphoma","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001598805,0.0003707114,0.0005224055,0.0003348818,0.0005048612,0.0003399395,0.0003411995,0.001230453,0.0005742118],"category_scores_gemma":[0.0006225117,0.0001733554,0.0003881164,0.0002440024,0.0003505482,0.0003572481,0.0003142249,0.001671322,0.0003167285],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004891304,"about_ca_system_score_gemma":0.0003370741,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001148385,"about_ca_topic_score_gemma":0.002992917,"domain_scores_codex":[0.9998623,0.00001937091,0.00001658984,0.00003250513,0.00002240764,0.00004680676],"domain_scores_gemma":[0.9995893,0.000100717,0.00004420063,0.00003407664,0.00002147888,0.0002102475],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"case_report","study_design_gemma":"case_report","study_design_scores_codex":[0.001639565,0.0006786233,0.02583837,0.0002979095,0.0001107306,0.8558033,0.0007567699,0.002198314,0.03307002,0.0005888825,0.002843892,0.07617369],"study_design_scores_gemma":[0.0003969495,0.005835035,0.05249867,0.00007116322,0.0001611745,0.9127558,0.0002117147,0.005314388,0.01415121,0.000660615,0.007890885,0.00005227856],"study_design_candidate":"case_report","study_design_consensus":"case_report","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9808971,0.004953134,0.002999388,0.003910906,0.0002329769,0.0001491181,0.0003058585,0.0001821256,0.006369565],"genre_scores_gemma":[0.9964635,0.0008438328,0.0006118065,0.0007098589,0.00009746908,0.00001349114,0.0001878508,0.00001226907,0.001059955],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001230453,"threshold_uncertainty_score":0.00354892,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01374179778838604,"score_gpt":0.3064699071207492,"score_spread":0.2927281093323632,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}